Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron 宣佈預賽。ASGCT 演示中的數據顯示，DB-OTO 在 24 周內將一個孩子的聽力改善到正常水平，在 6 周評估中觀察到第二個孩子的初次聽力改善
Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron 宣佈預賽。ASGCT 演示中的數據顯示，DB-OTO 在 24 周內將一個孩子的聽力改善到正常水平，在 6 周評估中觀察到第二個孩子的初次聽力改善
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。